Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist
Ruochen Zang,Liang Xue,Meifang Zhang,Xiaoyue Peng,Xionghao Li,Kaixin Du,Chuanqin Shi,Yuqian Liu,Yuxi Lin,Wenwei Han,Rilei Yu,Qian Wang,Jinbo Yang,Xin Wang,Tao Jiang
DOI: https://doi.org/10.1016/j.ejmech.2023.115184
IF: 7.088
2023-03-01
European Journal of Medicinal Chemistry
Abstract:Cyclic GMP-AMP synthase and stimulator of interferon genes (cGAS-STING) signaling stimulators, an essential innate immunity component, monitor invading pathogen DNA and damaged self-DNA, making them an appealing target for drug development. The natural STING agonist, 2'3'-cGAMP, mounts and stabilizes the STING homodimer to trigger an antiviral or antitumor immune responses. However, cyclic-dinucleotide-based STING agonists show limited clinical effects owing to their short half-lives. To explore whether STING-dimer stabilizers could trigger STING signaling instead of cyclic dinucleotide-based molecules, we analyzed the structural characteristics of STING to design and synthesize a series of compounds based on the covalent STING inhibitor C-170, three of which were 23, 26, and 27, exhibited STING-dependent immune activation, both in vitro and in vivo. Compound 23 could act synergistically with cGAMP and other STING agonists as a promising moderate STING agonist. This indicates that promoting STING dimerization is a promising strategy for designing next-generation STING agonists.
chemistry, medicinal